
Sign up to save your podcasts
Or


📢 New from the SOUL trial!
💊 Oral semaglutide cuts heart attack risk in T2DM 🫀 but shows no benefit for stroke 🧠or kidney disease 🧫.
A win for adherence, a push for CKM integration! 🔄💡 #Diabetes #Cardiology #NEJM #CKM #GLP1RA @doximity
By Dr RR Baliga, MD, MBA5
66 ratings
📢 New from the SOUL trial!
💊 Oral semaglutide cuts heart attack risk in T2DM 🫀 but shows no benefit for stroke 🧠or kidney disease 🧫.
A win for adherence, a push for CKM integration! 🔄💡 #Diabetes #Cardiology #NEJM #CKM #GLP1RA @doximity

905 Listeners

3,381 Listeners

20,577 Listeners